Here's a thinking process that leads to the suggested markdown report:

1.  **Understand the Goal:** The user wants me to act as an equity analyst extracting a credit rating report from raw HTML/text. I need to organize this information into a specific, well-structured Markdown report with predefined sections (Rating Action, Detailed Rationale, Key Rating Drivers - Strengths/Weaknesses, Liquidity, Outlook & Rating Sensitivity, Key Financial Indicators, Bank Facilities, Company & Subsidiaries).

2.  **Analyze the Source Text:**
    *   **Source:** Raw text scraped from a CRISIL Ratings webpage.
    *   **Subject:** Kovai Medical Center and Hospital Limited (KMCH).
    *   **Date:** December 31, 2024.
    *   **Agency:** CRISIL Ratings.
    *   **Ratings:** Long Term 'CRISIL AA-/Stable', Short Term 'CRISIL A1+'.
    *   **Total Facilities Rated:** Rs. 400 Crore (inferred from "Total Bank Loan Facilities Rated Rs.400 Crore" and Annexure breakdown).
    *   **Content:** Includes rationale, strengths, weaknesses, liquidity, outlook, financial indicators table, bank facilities breakup, company info, etc.
    *   **Noise:** There's a lot of boilerplate text at the end (disclaimers, about CRISIL, contact info, privacy notice). I need to filter this out and focus on the relevant data points for the required sections.

3.  **Map Content to Sections:**

    *   **## Rating Action**
        *   *Rating:* CRISIL AA-/Stable (LT), CRISIL A1+ (ST).
        *   *Outlook:* Stable.
        *   *Date:* December 31, 2024.
        *   *Agency:* CRISIL Ratings Limited.
        *   *Total Facilities:* Rs. 400 Crore.

    *   **## Detailed Rationale**
        *   *Summary:* Ratings reflect long vintage, promoter experience, diversified revenue streams, comfortable operating performance, strong financial risk profile. Offset by geographic concentration and regulatory risks.
        *   *Approach:* Standalone business and financial risk profiles considered.

    *   **## Key Rating Drivers — Strengths**
        *   *Driver 1:* Long vintage/experience (incorporated 1985, ops since 1990, promoters have 40+ years exp).
        *   *Driver 2:* Diversified revenue/stability (Healthcare 92%, Education 8%, stable margins, ROCE > 20%).
        *   *Driver 3:* Strong financial risk profile (Networth Rs 973cr, Gearing 0.40x, Interest coverage ~9.53x, Debt/EBITDA < 1x).

    *   **## Key Rating Drivers — Weaknesses**
        *   *Driver 1:* Geographic concentration (Coimbatore contributes ~90% revenue, flagship hospital ~75%). Plan to open in Chennai but medium term reliance remains high.
        *   *Driver 2:* Regulatory risk (Price caps on stents/implants, cash transaction limits, Supreme Court proposals).

    *   **## Liquidity**
        *   *Assessment:* Strong.
        *   *Cash:* Cash/Bank/FD around Rs 250 crore (as on Sept 30, 2024).
        *   *Working Capital:* Barely used limit due to negative cycle.
        *   *Accruals:* Annual accrual > Rs 300 crore sufficient for debt obligations (Rs 30-40 crore) + Capex.
        *   *Dividends:* Unlikely to pay dividends; reinvested for growth.

    *   **## Outlook & Rating Sensitivity**
        *   *Outlook:* Stable.
        *   *Basis:* Established presence, healthy efficiency, financial prudence expected.
        *   *Upward Factors:* Steady revenue growth, margin > 25%, geographical diversification.
        *   *Downward Factors:* Sluggish growth/margins leading to lower accrual, large debt-funded capex/acquisition pushing D/Ebitda > 2.25x.

    *   **## Key Financial Indicators**
        *   *Data:* Extract from the "Key Financial Indicators" table section (March 31, 2024 vs 2023).
        *   *Fields:* Operating income, PAT, PAT margin, Adjusted debt/Adjusted networth, Interest coverage.

    *   **## Bank Facilities**
        *   *Data:* Extract from "Annexure - Details of Bank Lenders & Facilities".
        *   *Structure:* Facility Type, Amount (Rs Cr), Lender, Rating.
        *   *Note:* Total needs to match roughly Rs 400 Cr (15+100+15+120.04+149.96 = ~400).

    *   **## Company & Subsidiaries**
        *   *Info:* Incorporation (1985), Location (Coimbatore), Beds (854 multispecialty + medical college hospital), Promoters (Dr Nalla G Palaniswami & Dr Thavamani Devi Palaniswami), Listing (BSE).
        *   *Subsidiaries/Expansion:* Satellite centers (City Center, Sulur, Kovilpalayam, Erode Speciality), KMCH Institute of Health Sciences & Research (Medical College).

4.  **Drafting the Report (Iterative Refinement):**
    *   *Formatting:* Use H2 headers as requested. Use bullet points for lists. Use Markdown tables for financial data and facilities.
    *   *Tone:* Professional, analytical, objective.
    *   *Cleaning:* Remove the disclaimer footer text, media contacts, and general "About CRISIL" info unless it pertains to the entity itself. Ensure numbers are formatted consistently (e.g., "Rs. X Crore").
    *   *Verification:* Check the total facilities calculation against the text.
        *   Bank Guarantee: 15
        *   LC: 100
        *   Overdraft: 15
        *   Term Loan 1: 120.04
        *   Term Loan 2: 149.96
        *   Sum: 15 + 100 + 15 + 120.04 + 149.96 = 400.00. Matches the "Rs.400 Crore" header.
    *   *Dates:* Ensure all dates are current (Dec 31, 2024 is the report date, financials are FY2024/FY2023).
    *   *Sensitivity:* Specifically mention the threshold "2.25 times" mentioned in downward factors.

5.  **Final Review:** Does it meet all constraints? Yes. Is it clean? Yes. Are tables readable? Yes.

6.  **Construct Output:** (Proceeding to generate the Markdown based on the thought process).
</think>

# Credit Rating Report: Kovai Medical Center and Hospital Limited

## Rating Action
| Parameter | Details |
| :--- | :--- |
| **Company Name** | Kovai Medical Center and Hospital Limited |
| **Agency** | CRISIL Ratings Limited |
| **Report Date** | December 31, 2024 |
| **Long Term Rating** | CRISIL AA-/Stable |
| **Short Term Rating** | CRISIL A1+ |
| **Total Facilities Rated** | Rs. 400 Crore |

*Note: None of the Directors on CRISIL Ratings Limited’s Board are members of the rating committee and thus do not participate in discussion or assignment of any ratings.*

## Detailed Rationale
CRISIL Ratings has assigned its ‘CRISIL AA-/Stable’ (LT) and ‘CRISIL A1+’ (ST) ratings to the bank facilities of Kovai Medical Center and Hospital Ltd (KMCH). 

The ratings reflect the company's long vintage, extensive experience of the promoters in the healthcare industry, diversified revenue streams (healthcare and education), comfortable operating performance, and a strong financial risk profile. These strengths are partially offset by geographic concentration in revenue and exposure to regulatory risks.

CRISIL Ratings has considered the standalone business and financial risk profiles of KMCH to arrive at these ratings.

## Key Rating Drivers — Strengths
*   **Long vintage and extensive industry experience of the promoters:**
    *   Incorporated in 1985 and commenced operations in 1990.
    *   Flagship multispecialty hospital established in Coimbatore with satellite centres in Coimbatore and Erode.
    *   Promoters, Dr Nalla G Palaniswami and Dr Thavamani Devi Palaniswami, possess over four decades of experience in the healthcare sector.
*   **Diversified revenue streams and comfortable operating performance:**
    *   Revenue is diversified across Healthcare (~92%) and Education (~8%) sectors.
    *   Recognized as a forerunner in transplant and gynaecology surgeries.
    *   Operating performance remained between 27-29% in the last three years, supported by stable healthcare margins and higher education margins.
    *   Return on capital employed was healthy at more than 20% in fiscal 2024.
*   **Strong financial risk profile:**
    *   Sizeable net worth of Rs 973 crore.
    *   Comfortable gearing of 0.40 times as on September 30, 2024.
    *   Improved debt protection metrics: Interest coverage ratio of around 9.53 times in fiscal 2024 (vs 6.44 times in fiscal 2023).
    *   Net cash accrual to adjusted debt ratio improved to 0.95 time (vs 0.42 time in fiscal 2023).
    *   Total debt to EBITDA ratio reduced to less than 1 time as on March 31, 2024 (from 1.64 times in FY2023).
    *   Medium-term capex of Rs 250-300 crore planned to be funded majorly through internal accrual.

## Key Rating Drivers — Weaknesses
*   **Geographic concentration in revenue:**
    *   High reliance on flagship hospital which contributed around 75% of revenue in fiscal 2024.
    *   Revenue from Coimbatore accounts for around 90%.
    *   Peripheral centres are smaller; dependency on Coimbatore likely to remain key driver over the medium term despite plans to establish a hospital in Chennai.
*   **Exposure to regulatory risk:**
    *   Exposure to price caps on cardiac stents and knee implants (impacted private hospitals significantly in FQ4 Fiscal 2017).
    *   Challenges faced due to cap on cash transactions up to Rs 2 lakh introduced in Fiscal 2018.
    *   Ongoing monitoring required regarding potential Supreme Court proposals to standardise prices for procedures across public and private hospitals.

## Liquidity
*   **Assessment:** Strong.
*   **Cash Reserves:** Cash, bank balance, and fixed deposits stand at around Rs 250 crore as on September 30, 2024.
*   **Working Capital Utilization:** Working capital limit barely used for the 12 months through November 2024 due to a negative working capital cycle and healthy liquidity.
*   **Debt Servicing Capacity:** Annual cash accrual of over Rs 300 crore is sufficient to meet debt obligations of Rs 30-40 crore over the medium term, alongside capex requirements.
*   **Capital Allocation:** Dividend payments unlikely over the medium term; cash flows to be reinvested to fund growth.
*   **Financial Flexibility:** Low gearing supports flexibility to withstand adverse conditions or business downturns.

## Outlook & Rating Sensitivity
*   **Outlook:** **Stable**
    *   CRISIL believes KMCH will continue to benefit from its established presence in Coimbatore and healthy operating efficiency. The company is expected to maintain financial prudence and sustain healthy credit metrics while pursuing growth.
*   **Upward Rating Factors:**
    *   Steady revenue growth and stable healthy operating margin over 25%, leading to higher cash accrual.
    *   Geographical diversification in the hospital business while maintaining a strong financial risk profile.
*   **Downward Rating Factors:**
    *   Sluggish revenue growth or decline in operating margin leading to lower net cash accrual.
    *   Additional large debt-funded capex or acquisition weakening key credit metrics, specifically if the debt to EBITDA ratio exceeds 2.25 times.

## Key Financial Indicators
*(As on / for the period ended March 31)*

| Indicator | FY 2024 | FY 2023 |
| :--- | :--- | :--- |
| **Operating Income (Rs. Crore)** | 1,219.55 | 1,019.74 |
| **Reported Profit After Tax - PAT (Rs. Crore)** | 179.73 | 115.77 |
| **PAT Margin (%)** | 14.49 | 11.18 |
| **Adjusted Debt / Adjusted Networth (Times)** | 0.31 | 0.66 |
| **Interest Coverage (Times)** | 9.53 | 6.44 |

## Bank Facilities
*(Details from Annexure - Details of Bank Lenders & Facilities)*

| Facility Type | Amount (Rs. Crore) | Name of Lender | Assigned Rating |
| :--- | :--- | :--- | :--- |
| Bank Guarantee | 15.00 | Indian Bank | CRISIL A1+ |
| Inland/Import Letter of Credit | 100.00 | Indian Bank | CRISIL A1+ |
| Secured Overdraft Facility | 15.00 | Indian Bank | CRISIL A1+ |
| Term Loan | 120.04 | Indian Overseas Bank | CRISIL AA-/Stable |
| Term Loan | 149.96 | Indian Bank | CRISIL AA-/Stable |
| **Total Fund Based Facilities** | **285.00** | - | - |
| **Total Non-Fund Based Facilities** | **115.00** | - | - |
| **Grand Total** | **400.00** | - | - |

## Company & Subsidiaries
*   **Incorporation:** 1985 (Operations commenced 1990).
*   **Listing:** Bombay Stock Exchange (BSE).
*   **Primary Operations:** 854-bed multispecialty hospital in Coimbatore.
*   **Satellite Centres:**
    *   Coimbatore: City Center, Sulur Hospital, Kovilpalayam Hospital.
    *   Erode: Erode Speciality Hospital.
*   **Education Wing:** KMCH Institute of Health Sciences & Research (started 2019-2020). Offers MBBS degree course (annual intake 150 students) along with a 750-bed medical college hospital.
*   **Promoters:** Dr Nalla G Palaniswami and Dr Thavamani Devi Palaniswami.
*   **Consolidated Entities:** Not explicitly detailed in text other than "Group" references regarding educational and hospital wings.

***Disclaimer:** This report is generated based on extracted text from CRISIL Ratings Limited. It does not constitute investment advice. Refer to the original disclosure document for full legal disclaimers and complexity level details.*